by Frank Grimsey Jones | Aug 21, 2021 | Health economic modelling, Market access
Health economic modelling is a process for synthesising and comparing the costs and benefits of new (proposed) and existing medicines or devices in order to make decisions about which interventions may lead to the best patient outcomes. It is a key component of the...
by Kristen Markus | Aug 13, 2021 | Clinical trial, Evidence generation, Health outcomes, Market access, Medical affairs
Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease processes and progression. This rapidly evolving knowledge must be integrated into ongoing research and development of new...
by Kristen Markus | Aug 13, 2021 | Evidence synthesis, Health outcomes, Healthcare, Market access
What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that informs their thinking. But how can they take into account...
